Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Vistagen Therapeutics Inc (NASDAQ: VTGN) closed the day trading at $0.78 up 5.11% from the previous closing price of $0.74. In other words, the price has increased by $5.11 from its previous closing price. On the day, 7.38 million shares were traded. VTGN stock price reached its highest trading level at $0.7801 during the session, while it also had its lowest trading level at $0.6751.
Ratios:
For a better understanding of VTGN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTGN now has a Market Capitalization of 30719564 and an Enterprise Value of -44590440. For the stock, the TTM Price-to-Sale (P/S) ratio is 43.89 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -61.845 whereas that against EBITDA is 0.683.
Stock Price History:
The Beta on a monthly basis for VTGN is 0.38, which has changed by -0.69649804 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, VTGN has reached a high of $5.14, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is -80.49%, while the 200-Day Moving Average is calculated to be -74.27%.
Shares Statistics:
Over the past 3-months, VTGN traded about 2.02M shares per day on average, while over the past 10 days, VTGN traded about 9804940 shares per day. A total of 38.89M shares are outstanding, with a floating share count of 33.66M. Insiders hold about 14.78% of the company’s shares, while institutions hold 44.98% stake in the company. Shares short for VTGN as of 1764288000 were 1274319 with a Short Ratio of 0.63, compared to 1761868800 on 1357492. Therefore, it implies a Short% of Shares Outstanding of 1274319 and a Short% of Float of 4.61.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of Vistagen Therapeutics Inc (VTGN) in the stock market.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.2 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.73 and -$1.99 for the fiscal current year, implying an average EPS of -$1.83. EPS for the following year is -$1.23, with 4.0 analysts recommending between -$0.8 and -$1.69.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for VTGN’s current fiscal year. The highest revenue estimate was $1.4M, while the lowest revenue estimate was $500k, resulting in an average revenue estimate of $884k. In the same quarter a year ago, actual revenue was $486k
